Post-therapeutic dosimetric evaluation of 166Ho radioembolization for liver malignancies: Impact of software on tumor and liver doses
Advances in Radiotherapy & Nuclear Medicine · 2025
DOI: 10.36922/arnm025220023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Radiotherapy & Nuclear Medicine, 2025. Verfasst von Rita Albergueiro und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Transarterial radioembolization using holmium-166 microspheres is a promising treatment for primary and secondary liver malignancies. Accurate post-therapeutic dosimetry is critical for optimizing outcomes, particularly in voxel-based dose assessment using quantitative single-photon emission computed tomography/ computed tomography (SPECT/CT). This study aimed to evaluate the impact of software choice and calibration method on absorbed dose estimates to the liver and tumor, by comparing two advanced dosimetry platforms: Hermia Voxel Dosimetry™ and Q-Suite™. Despite the recent discontinuation of 166Ho-microsphere production, such studies remain highly relevant given the global emphasis on personalized dosimetry, quantitative imaging in nuclear medicine, and potential applicability to other therapeutic radiopharmaceuticals and future microsphere technologies. Fourteen patients underwent a scout procedure, followed by therapy and post-treatment SPECT/CT imaging. Initial analysis revealed substantially lower mean liver and tumor doses with Hermia (12 ± 4 Gy and 58 ± 23 Gy) compared to Q-Suite (44 ± 9 Gy and 209 ± 83 Gy), with statistically significant differences (p=0.002 and p
Zitieren
APA
Albergueiro, R., Silva, R., & Santos, J. (2025). Post-therapeutic dosimetric evaluation of 166Ho radioembolization for liver malignancies: Impact of software on tumor and liver doses. Advances in Radiotherapy & Nuclear Medicine. https://doi.org/10.36922/arnm025220023
Vancouver
Albergueiro R, Silva R, Santos J. Post-therapeutic dosimetric evaluation of 166Ho radioembolization for liver malignancies: Impact of software on tumor and liver doses. Advances in Radiotherapy & Nuclear Medicine. 2025. doi:10.36922/arnm025220023
BibTeX
@article{Albergueiro2025,
author = {Albergueiro, Rita and Silva, Rafael and Santos, João},
title = {Post-therapeutic dosimetric evaluation of 166Ho radioembolization for liver malignancies: Impact of software on tumor and liver doses},
journal = {Advances in Radiotherapy & Nuclear Medicine},
year = {2025},
doi = {10.36922/arnm025220023}
}
EUVIMED